Skip to main content

Four years after the British coalition government of David Cameron unveiled efforts to fend off criticism that it was failing to provide expensive new cancer drugs, the strains in the system are again beginning to show.

In 2010, it created the Cancer Drugs Fund to pay for medicines rejected as not cost effective by the National Institute for Health and Care Excellence (Nice). Yet the fund not only undermined Nice’s authority; it has also run into difficulties after significantly overspending its budget of £200m a year.

By Andrew Jack, FT

To read the full article please visit this link and register with FT.com www.ft.com/cms/s/0/2e417874-1bcf-11e4-9db1-00144feabdc0.html#ixzz3EmY7LA9e

More News

Medics from Palestine, Qatar and the UK convene to help treat pain in children in war zones
News
29 Apr 2024

Medics from Palestine, Qatar and the UK convene to help treat pain in children in war zones

Read More
World Innovation Summit for Health Announces 2024 Global Healthcare Innovation Competition at Web Summit
News
18 Mar 2024

World Innovation Summit for Health Announces 2024 Global Healthcare Innovation Competition at Web Summit

Read More
World Innovation Summit for Health hosts session on post-pandemic global health resilience at Doha Forum
News
14 Dec 2023

World Innovation Summit for Health hosts session on post-pandemic global health resilience at Doha Forum

Read More